CORD-19:fff600839441a60bb883d5f4328aa3227e127d1d / 13595-13932 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T103","span":{"begin":0,"end":337},"obj":"Sentence"},{"id":"TextSentencer_T103","span":{"begin":0,"end":337},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"When PBMC from the PRV and LV-PRV group were stimulated in vitro with NIA-3 virus, PRV-speci®c killing (i.e. killing of PRV-infected L14 cells and killing of uninfected L14 cells) increased between weeks 3 and 6 after PRV vaccination (up to 30% of PRVinfected target cells were killed compared with up to 15% of uninfected target cells)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T103","span":{"begin":0,"end":337},"obj":"Sentence"}],"text":"When PBMC from the PRV and LV-PRV group were stimulated in vitro with NIA-3 virus, PRV-speci®c killing (i.e. killing of PRV-infected L14 cells and killing of uninfected L14 cells) increased between weeks 3 and 6 after PRV vaccination (up to 30% of PRVinfected target cells were killed compared with up to 15% of uninfected target cells)."}